Particularly indicated in cases of postmenopausal breast cancer are treatments that modulate ER function using SERMs and SERDs as well as powerful and highly selective treatments that suppress estrogen synthesis using third-generation AIs. The gene discussed is ESR1; the disease is breast cancer.